During the past decade, Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin" #1 collaborator was "Celgene Corporation" with 1 trials as a collaborator, "Deutsches Krebsforschungszentrum (DKFZ)" with 1 trials as a collaborator, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials as a collaborator, "Institut für Medizinische Biometrie" with 1 trials as a collaborator and "Molecular Health GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin" are "Anemia" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Pancreatic Ductal Adenocarcinoma" (1 trials). Many other conditions were trialed in "Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin" in a lesser frequency.

Most popular intervention types in "Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-fluorouracil" (1 trials), "Capecitabine" (1 trials), "Folinic acid" (1 trials), "Gemcitabine" (1 trials) and "Irinotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsmedizin Rostock Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".